Literature DB >> 6159312

Protective effect of interferon on target cells exposed to cellular cytotoxicity.

M Bergeret, A Grégoire, C Chany.   

Abstract

In order to explore by immunological methods the interferon-induced cell membrane modulation, the effect of interferon in parental and monkey-mouse hybrid cells was studied in the presence of sensitized lymphocytes from isologous mice. After primary immunization to the hybrids, both parental interferons increased the lymphocyte-induced specific cytotoxicity in the same hybrid cells used as targets. In addition, a significnt increase of spontaneous lysis due to the two interferons was observed. In contrast, after secondary sensitization, in spite of the higher specific cytotoxicity induced by the lymphocytes, the same interferon preparation significantly protected the cells. These results are probably related to a greater number of sensitized effector cells after secondary sensitizationn. It is likely that, although interferon increases the affinity of sensitized T lymphocytes for the target cell membrane, in case of unsuccessful encounters, the target cells become resistant to new hits. Interferon could augment the number of such immune cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159312      PMCID: PMC1458119     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  10 in total

1.  Antibodies to a cell-surface component coded by human chromosome 21 inhibit action of interferon.

Authors:  M Revel; D Bash; F H Ruddle
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

Review 2.  Membrane-bound interferon specific cell receptor system: role in the establishment and amplification of the antiviral state.

Authors:  C Chany
Journal:  Biomedicine       Date:  1976-06

3.  Mechanism of interferon uptake in parental and somatic monkey-mouse hybrid cells.

Authors:  C Chany; A Grégoire; M Vignal; J Lemaitre-Moncuit; P Brown; F Besançon; H Suarez; R Cassingena
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

4.  Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes.

Authors:  P Lindahl; P Leary; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

5.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

6.  Use of monkey-mouse hybrid cells for the study of the cellular regualtion of interferon production and action.

Authors:  R Cassingena; C Chany; M Vignal; H Suarez; S Estrade; P Lazar
Journal:  Proc Natl Acad Sci U S A       Date:  1971-03       Impact factor: 11.205

7.  Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity.

Authors:  K T Brunner; J Mauel; H Rudolf; B Chapuis
Journal:  Immunology       Date:  1970-04       Impact factor: 7.397

8.  Interferon binding: the first step in establishment of antiviral activity.

Authors:  R M Friedman
Journal:  Science       Date:  1967-06-30       Impact factor: 47.728

9.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

10.  THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES.

Authors:  A E REIF; J M ALLEN
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

  10 in total
  6 in total

1.  Antitumor therapy based on the use of an immune modulator, arginine butyrate and interferon.

Authors:  C Chany; I Cerutti
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

2.  Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon.

Authors:  E D Ball; K E Nichols; O S Pettengill; G D Sorenson; M W Fanger
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Experimental study of transplacental passage of alpha interferon by two assay techniques.

Authors:  A Waysbort; M Giroux; V Mansat; M Teixeira; J C Dumas; J Puel
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

4.  Presence of an acid-labile alpha-interferon in sera from fetuses and children with congenital rubella.

Authors:  P Lebon; F Daffos; A Checoury; L Grangeot-Keros; F Forestier; J E Toublanc
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

5.  Interferon effect on cytolytic T lymphocytes in a single cycle assay.

Authors:  M Bergeret; M Fouchard; A Gregoire; C Chany; D Zagury
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

6.  Unusual human interferons produced by virus-infected amniotic membranes.

Authors:  P Duc-Goiran; B Robert-Galliot; T Chudzio; C Chany
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.